Topiramate Tablet, Film Coated
Product Images NDC 80425-0398

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 80425-0398). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (7f64694c 6a9a 4ddb 839e Faf17246c2a4 01)

Structured Product Formula For Topiramate (7f64694c 6a9a 4ddb 839e Faf17246c2a4 01)
Chemical structure diagram of topiramate, showing its molecular framework including oxygen, sulfur, nitrogen atoms, and characteristic ring and functional groups.*
FDA Label Image

Structured Product Formula For Topiramate (7f64694c 6a9a 4ddb 839e Faf17246c2a4 02)

Structured Product Formula For Topiramate (7f64694c 6a9a 4ddb 839e Faf17246c2a4 02)
A Kaplan-Meier cumulative incidence plot showing time to first seizure for patients taking topiramate at doses of 50 mg/day and 400 mg/day. The y-axis represents cumulative rates for time to first seizure, and the x-axis shows time in days up to 500. Two curves display the comparison between the two dosage groups with a noted p-value of 0.0002 indicating statistical significance.*
FDA Label Image

Topiramate Tablets Usp (7f64694c 6a9a 4ddb 839e Faf17246c2a4 03)

Topiramate Tablets Usp (7f64694c 6a9a 4ddb 839e Faf17246c2a4 03)
A bar chart showing the change from baseline to double-blind phase in average monthly migraine period rate for placebo and various topiramate dosages (50 mg/day, 100 mg/day, 200 mg/day) across two studies. The vertical axis measures change in migraine rate, with values decreasing as dosage increases. Study 11 and Study 12 results are distinguished by bar shading.*
FDA Label Image

Topiramate 100mg #30 (Topiramate 100mg 80425 0398 01)

Topiramate 100mg #30 (Topiramate 100mg 80425 0398 01)
Topiramate 100 mg tablet film coated, packaged by Advanced Rx of Tennessee, LLC, with a quantity of 30 tablets. The label references comparison to Topamax and includes storage instructions at 20°-25°C (68°-77°F). The label also displays an expiration date of 7/31/2025 and a source NDC.*
FDA Label Image

Topiramate 100mg #60 (Topiramate 100mg 80425 0398 02)

Topiramate 100mg #60 (Topiramate 100mg 80425 0398 02)
Topiramate 100 mg film-coated tablet label from Advanced Rx of Tennessee, LLC, displaying storage instructions, comparison to Topamax, 60 tablets per container, and expiration date of 7/31/2025. The label includes the NDC 80425-0398 and manufacturer Zydus Pharmaceuticals.*
FDA Label Image

Topiramate 100mg #90 (Topiramate 100mg 80425 0398 03)

Topiramate 100mg #90 (Topiramate 100mg 80425 0398 03)
Topiramate 100 mg film-coated tablet carton labeled by Advanced Rx of Tennessee, LLC. The label indicates the product is a prescription drug with 90 tablets per package. Storage instructions recommend 20-25°C. The label compares the product to Topamax and includes manufacturer information, lot number, and expiration date fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.